Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,000,935
-$2,218,095 QoQ
Shares Held
33,846
-31.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $27,399,554 across 15 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
162,424 | $5,743,312 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
8,887 | $5,269,813 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
36,232 | $4,773,203 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
33,846 | $4,000,935 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
354,260 | $3,372,555 | |
| 6 | VTRS |
Viatris Inc
|
99,502 | $1,344,272 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
216,623 | $760,346 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
85,199 | $707,151 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,000,935 | 33,846 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,219,030 | 49,428 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,410,815 | 50,648 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,561,391 | 48,486 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,158,652 | 43,478 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,663,476 | 53,173 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,426,303 | 48,246 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,013,506 | 51,993 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,488,758 | 50,167 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,662,840 | 48,958 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,700,565 | 50,009 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,047,373 | 46,730 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,211,013 | 43,325 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,160,962 | 42,040 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,932,205 | 26,517 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,215,146 | 12,887 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,172,083 | 16,820 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,793,969 | 19,645 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,652,355 | 18,813 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,573,631 | 13,810 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,882,358 | 11,953 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,923,772 | 11,624 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,812,951 | 10,963 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,769,186 | 12,910 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $562,440 | 4,779 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||